Prevalence of CSF HIV VIRAL Escape and Associations With Neurocognitive Outcomes Among HIV-Associated Meningitis Survivors: A Cohort Study - Takeaways - MDSpire

Prevalence of CSF HIV VIRAL Escape and Associations With Neurocognitive Outcomes Among HIV-Associated Meningitis Survivors: A Cohort Study

  • By

  • Laura Nsangi

  • Gila Hale

  • Biyue Dai

  • Kathy Huppler Hullsiek

  • Asmus Tukundane

  • Alice Namudde

  • Grace B Menya

  • Peruth Ayebare

  • Lydia Nankungu

  • Olivie C Namuju

  • Susan Mulwana

  • Mable Kabahubya

  • David B Meya

  • David R Boulware

  • Fiona V Cresswell

  • Nathan C Bahr

  • Mahsa Abassi

  • Jayne Ellis

  • February 12, 2026

  • 0 min

Share

  • 1

    Secondary cerebrospinal fluid (CSF) HIV viral escape was prevalent in 43% of Ugandan adults surviving HIV-associated meningitis.

  • 2

    CSF viral escape was associated with better neurocognitive outcomes at 3 months post-meningitis diagnosis.

  • 3

    Participants with secondary CSF HIV viral escape were more likely to be antiretroviral therapy (ART)–naïve and exhibit CSF pleocytosis.

  • 4

    The study included 93 participants, with 69% having cryptococcal meningitis and a median age of 35 years.

  • 5

    Overall, 75% of participants had plasma viremia, and 78% had CSF HIV viremia, indicating significant viral presence.

Original Source(s)

Related Content